A Single-Blind, Randomized, Placebo Controlled, Rising Multiple Dose, Safety, Tolerability and Pharmacokinetic Study of RBx 10017609 in Healthy Adult Male Human Volunteers

Trial Profile

A Single-Blind, Randomized, Placebo Controlled, Rising Multiple Dose, Safety, Tolerability and Pharmacokinetic Study of RBx 10017609 in Healthy Adult Male Human Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs RBx 10017609 (Primary)
  • Indications Obstructive airway disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Jul 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
    • 24 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top